UnicomIG
0.1.0 - ci-build

UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/ and changes regularly. See the Directory of published versions

Example Bundle: 007-Jangee-002mg-3mg-Film-coated-tablet-EE-FullProduct

Jangee 0.02 mg/3 mg, õhukese polümeerikattega tabletid

MPID: EE-100005719-2603

Full name: Jangee 0.02 mg/3 mg, õhukese polümeerikattega tabletid

- Invented name part: Jangee

- Strength part: 0.02 mg/3 mg

- Pharmaceutical dose form part: Õhukese polümeerikattega tabletid

Name usage: Estonian (Republic of Estonia)

Authorised dose form: Film-coated tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000095785 drospirenone and ethinylestradiol

Marketing Authorisation 1 of 1

Authorisation number: 650509

Region: Republic of Estonia

Marketing authorisation holder: Exeltis Baltics UAB

Identifier:

  • LOC-100005719

Status: Valid - Renewed/Varied (2016-09-14)

Package 1 of 1

PCID: EE-100005719-2603-1331019

Description:
Alumiiniumfooliumiga kaetud PVC/PVDC blistrid. Pakendi suurus: 1 x 21 õhukese polümeerikattega tabletti

Marketing status:

  • Republic of Estonia: Marketed

Pack size:

  • 21 tablet

Package: 1 Box

Containing:

Package: 1 Box (Cardboard)

Containing:

Package: 1 Blister (Aluminium) (PolyVinyl Chloride) (PolyVinylidene Chloride)

Containing: 21 tablet

Manufactured Item

Dose form: Film-coated tablet

Unit of presentation: tablet

Ingredient

Role: Active

Substance: Ethinylestradiol betadex clathrate

Reference strength:
Ethinylestradiol 0.02 milligram(s) / 1 tablet

Ingredient

Role: Active

Substance: drospirenone

Presentation strength: 3 milligram(s) / 1 tablet

Reference strength:
drospirenone 3 milligram(s) / 1 tablet

Administrable Product (1 of 1)

Dose form: Film-coated tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Ethinylestradiol betadex clathrate

Reference strength:
Ethinylestradiol 0.02 milligram(s) / 1 tablet

Ingredient

Role: Active

Substance: drospirenone

Presentation strength: 3 milligram(s) / 1 tablet

Reference strength:
drospirenone 3 milligram(s) / 1 tablet